RXi Pharmaceuticals is a discovery-stage biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi) for the treatment of serious human diseases. The company has developed novel and proprietary nanotransporters that have been shown to deliver RNAi compounds to target tissues in animal models.

Address: One Innovation Drive (Biotech 3, 3rd floor)
City: Worcester
State/Province: Massachusetts
Postcode: 01605
Country/Region: USA
visit website button
Back to Nanotechnology Links Directory